Publications | Lund University Publications

251 – 260 of 324

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=issn+exact+%221351-8216%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
25
26
27
28
…
33
next »

2006
Mark Inhibitor treatment in haemophilas A and B: Summary statement for the 2006 International Consensus Conference
Berntorp, Erik ^LU ; Shapiro, A ; Astermark, Jan ^LU ; Blanchette, V. S ; Collins, P. W ; Dimichele, D ; Escuriola, C ; Hay, C. R. M ; Hoots, W. K and Leissinger, C. A , et al. (2006) In Haemophilia 12. p.41281-41281
- Contribution to journal › Debate/Note/Editorial
Mark Pharmacoeconomics of factor dosing in the haemophilia population.
Berntorp, Erik ^LU (2006) In Haemophilia 12 Suppl 4. p.70-73
- Contribution to journal › Article
Mark Von Willebrand's disease: clinical management
Federici, AB ; Castaman, G ; Thompson, A and Berntorp, Erik ^LU (2006) In Haemophilia 12(s3). p.152-158
- Contribution to journal › Article
Mark Basic aspects of inhibitors to factors VIII and IX and the influence of non-genetic risk factors.
Astermark, Jan ^LU (2006) In Haemophilia 12 Suppl 6. p.41499-41499
- Contribution to journal › Article
Mark Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
Astermark, Jan ^LU ; Morado, M ; Rocino, A ; van den Berg, H M ; von Depka, M ; Gringeri, A ; Mantovani, L ; Garrido, R P ; Schiavoni, M and Villar, A , et al. (2006) In Haemophilia 12(4). p.363-371
- Contribution to journal › Article
Mark Options for treating acute bleeds in addition to bypassing agents: extracorporeal immunoadsorption, FVIII/FIX, desmopressin and antifibrinolytics.
Berntorp, Erik ^LU (2006) In Haemophilia 12(Suppl 6). p.62-65
- Contribution to journal › Article
Mark Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A
Franchini, M ; Girelli, D ; Olivieri, O ; Castaman, G ; Lippi, G ; Poli, G ; Salvagno, GL ; Tagariello, G ; Giuffrida, A and De Gironcoli, M , et al. (2006) In Haemophilia 12(4). p.448-451
- Contribution to journal › Article
Mark Compliance with treatment and understanding of own disease in patients with severe and moderate haemophilia
Lindvall, Karin ^LU ; Colstrup, L ; Wollter, IM ; Klemenz, G ; Loogna, K ; Gronhaug, S and Thykjaer, H (2006) In Haemophilia 12(1). p.47-51
- Contribution to journal › Article
Mark Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia.
Astermark, Jan ^LU (2006) In Haemophilia 12 Suppl 3. p.52-60
- Contribution to journal › Article
Mark Recent developments in clinimetric instruments
Beeton, K ; De Kleijn, P ; Hilliard, P ; Funk, S ; Zourikian, N ; Bergstrom, BM ; Engelbert, RHH ; Van der Net, JJ ; Manco-Johnson, MJ and Petrini, P , et al. (2006) In Haemophilia 12(Suppl. 3). p.102-107
- Contribution to journal › Article

« previous
1
…
25
26
27
28
…
33
next »

your query:: Remove issn: 1351-8216